Nothing comparable since the round — shown at its later-stage round, Oct 2021 ($17.3M post-money).
- ·9 fund marks: filer, period, implied $/share
Membership and data by Private Market View
Valuation timeline
0 priced rounds · 32 daily marks since · Sep 2026 – Oct 2026Membership and data by Private Market View
Resonant Therapeutics funding history
1 rounds| Date | Round | Raised | Post-money | $/share |
|---|---|---|---|---|
| Oct 2021 | Seed Round | $2.5M | ▮ | ▮ |
Membership and data by Private Market View
Resonant Therapeutics valuation
Resonant Therapeutics is valued at approximately $17.3 million as of Oct 2026. The figure is set by institutional fund marks. The reference point is its later-stage round in Oct 2021, at a $17.3 million post-money valuation.
Recent activity
In the last 90 days, Resonant Therapeutics's record added 3 institutional fund marks (latest period Jul 2026).
How much has Resonant Therapeutics raised?
Resonant Therapeutics has raised $6.1 million in total; 1 of its rounds is on record. The largest on record was a $2.5 million seed round in Oct 2021.
Resonant Therapeutics has filed 1 Form D with the SEC, most recently in Oct 2021 ($2.5 million sold to 16 investors).
Institutional holders and vehicles
1 SEC-registered fund reported 9 fair-value marks on Resonant Therapeutics between Apr 2025 and Jul 2026, in their N-PORT filings. Filer-level marks and implied per-share values are available to Pro members.
How Resonant Therapeutics's valuation is determined
Private company valuations aren’t quoted on an exchange — they’re established in moments: a priced funding round sets a post-money valuation, secondary trades print at a price per share, and SEC-registered funds holding the stock report fair-value marks in their N-PORT filings.
For Resonant Therapeutics, the most current credible signal sets the number and the older ones confirm it: a live secondary-market price first, then three or more recent prints, then institutional fund marks, and otherwise the last priced round, which never decays. The valuation is the last round’s post-money moved by the price change since that round, so no share count is assumed. Today it is set by institutional fund marks. Question about this number? Full methodology →
Frequently asked about Resonant Therapeutics
- What is Resonant Therapeutics worth?
- Resonant Therapeutics is valued at $17.3M as of Oct 2026. Nothing comparable since the round — shown at its later-stage round, Oct 2021 ($17.3M post-money).
- How much has Resonant Therapeutics raised?
- Resonant Therapeutics has raised $6.1M in total funding across 1 recorded rounds.
- When did Resonant Therapeutics last raise?
- Resonant Therapeutics last raised in Oct 2021 (Seed Round), raising $2.5M.